Research Article
A First Step to a Biomarker of Curative Surgery in Colorectal Cancer by Liquid Biopsy of Methylated Septin 9 Gene
Table 3
Clinical, tumour stage and localization compared with the results of SEPT9 blood test in preoperative and postoperative samples. M: male; F: female.
| Patient | Age | Sex | Tumour stage | Localization | Preoperative SEPT9 | Recurrence/persistence | Postoperative SEPT9 |
| 1 | 60 | M | T3N1a | Right colon | Positive | No | Negative | 2 | 74 | F | T1N2a | Right colon | Positive | Retroperitoneal lymph nodes metastases | Positive | 3 | 75 | M | T3N1a | Left and urologic tumour | Positive | No | Negative | 4 | 66 | F | T4N2M1b | Sigmoid colon | Positive | Liver metastases | Positive | 5 | 66 | M | T3N2M1b | Right colon | Positive | Peritoneal carcinomatosis | Positive | 6 | 73 | F | T4N0 | Sigmoid colon | Positive | No | Negative | 7 | 73 | F | T4N2M1b | Sigmoid colon | Positive | Pulmonary metastases | Positive | 8 | 53 | F | T3N0 Lynch syndrome | Right colon | Negative | No | Negative | 9 | 63 | F | T3N0 | Right colon | Negative | No | Negative | 10 | 72 | F | T3N0 | Right colon | Positive | No | Negative |
|
|